
    
      This is a 12-week, double blind, placebo controlled, dose ranging study to evaluate the
      efficacy of gabapentin in treating outpatients with alcohol dependence. Subjects receive
      900mg or 1800mg gabapentin or placebo daily for 12 weeks accompanied by weekly standardized
      counseling for alcohol-related behavior, with assessments of alcohol consumption, mood, sleep
      and alcohol-craving performed each week.
    
  